RAPP
Rapport Therapeutics, Inc. Common Stock
NASDAQ: RAPP · HEALTHCARE · BIOTECHNOLOGY
$33.00
-2.19% today
Updated 2026-04-29
Market cap
$1.58B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.86
Dividend yield
—
52W range
$8 – $42
Volume
0.3M
Rapport Therapeutics, Inc. Common Stock (RAPP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-3.24M | $-27.18M | $-64.83M | $-87.47M |
| Capital expenditures | $284000.00 | $1.64M | $2.40M | $616000.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $609818.00 | $3.52M | $10.23M | $18.86M |
| Free cash flow | $-3.53M | $-28.82M | $-67.23M | $-88.09M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |